Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2002

01-07-2002 | Meeting abstract

Is it safe to allow general practitioners open access to breast imaging?

Authors: GR Clough, A Hill, JC Liston

Published in: Breast Cancer Research | Special Issue 1/2002

Login to get access

Excerpt

Many departments in the UK do not allow general practitioners open access for breast imaging. Royal College of Radiologists guidelines [1] published in 1999 recommend that direct referral of women by general practitioners for breast imaging should be controlled so that women with conditions requiring referral to a breast surgeon [2] are not inappropriately managed. To avoid overwhelming the already busy symptomatic breast clinics in Leeds, it was decided that direct access for breast imaging should continue but be audited. …
Literature
1.
Guidance on Screening and Symptomatic Breast Imaging. Royal College of Radiologists;. December 1999
2.
Guidelines for Referral of Patients with Breast Problems. NHSBSP. 1995
Metadata
Title
Is it safe to allow general practitioners open access to breast imaging?
Authors
GR Clough
A Hill
JC Liston
Publication date
01-07-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr526

Other articles of this Special Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue

Meeting abstract

Hormone replacement therapy (HRT): indications and side effects

Meeting abstract

A review of screen detected breast cancers among aboriginal women in Western Australia

Meeting abstract

Can ultrasound reliably localise radial scars (RS)/complex sclerosing lesions (CSL) prior to excision biopsy?

Meeting abstract

Diagnosis of dermal calcification

Meeting abstract

It ain't what you do, it's the way that you do it – that's what gets results

Meeting abstract

Image features of true positive and false negative cancers in screening mammograms
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits